Skip to content
OpenCapital
Get started

Quest Diagnostics DGX DIS business — D&A

Other segment segments

General corporate activities
$38M-2.6%
All other operating segments
$3M-25.0%

Similar metrics at other companies

Opko Health logo
OPKDiagnostics — D&A
$3.93M-31.1%
Flexible Solutions International logo
FSID&A
$509.5K+9.5%
Amplitech Group, Inc. logo
AMPGDistribution — D&A
$31.17K+8.3%
Amphenol logo
APHInterconnect And Sensor Systems — D&A
$40M+15.3%
ESAB logo
ESABD&A
$6.54M+52.7%
Asset Entities logo
ASSTMedical Device — D&A
$32K—

Other financials

Income statement

See full
Revenue$2.9B+9.2%
Gross profit$942.0M+9.2%
Operating income$399.0M+15.3%
Net income$252.0M+14.5%
EPS (diluted)$2.24+15.5%

Balance sheet

See full
Cash & equivalents$393.0M+109%
Total debt$6.4B-2.5%
Total equity$7.4B+6.3%
Total assets$16.7B+5.5%

Cash flow

See full
Operating cash flow$278.0M-11.5%
CapEx$114.0M-2.6%
Free cash flow$164.0M-16.8%

Valuation

See full
Market cap$23.46B+20.8%
Enterprise value$29.48B+15.7%
P/E22.9×+2.5×
P/S2.1×+0.2×

Profitability

See full
Gross margin33.2%+0.4pp
Operating margin14.3%+0.6pp
Net margin9.1%+0.2pp
FCF margin11.8%+1.4pp

Returns & leverage

See full
Return on equity14.3%+0.9pp
Debt / equity0.9×-0.1×
Current ratio1.2×-0.3×

Where this comes from

Reported directly by Quest Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Quest Diagnostics’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quest Diagnostics's dis business — d&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Quest Diagnostics's DIS business — D&A?
Quest Diagnostics (DGX) reported DIS business — D&A of $106M in Q1 2026.
How has Quest Diagnostics's DIS business — D&A changed year-over-year?
Quest Diagnostics's DIS business — D&A increased by 9.3% year-over-year, from $97M to $106M.
What is the long-term trend for Quest Diagnostics's DIS business — D&A?
Over 4 years (2021 to 2025), Quest Diagnostics's DIS business — D&A has grown at a 8.0% compound annual growth rate (CAGR), from $294M to $400M.
What does DIS business — D&A mean?
This metric reflects the non-cash allocation of the cost of tangible and intangible assets used by the Diagnostic Information Services segment over their useful lives. It provides insight into the capital intensity and the aging of the segment's asset base.